138 related articles for article (PubMed ID: 9369354)
1. Ketotifen prevents gastric hyperemia induced by intracisternal thyrotropin-releasing hormone at a low dose.
Király A; Süto G; Guth PH; Taché Y
Eur J Pharmacol; 1997 Sep; 334(2-3):241-7. PubMed ID: 9369354
[TBL] [Abstract][Full Text] [Related]
2. Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketotifen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue.
Király A; Süto G; Tam B; Hermann V; Mózsik G
J Physiol Paris; 2000; 94(2):131-4. PubMed ID: 10791694
[TBL] [Abstract][Full Text] [Related]
3. Peripheral mediators involved in gastric hyperemia to vagal activation by central TRH analog in rats.
Király A; Sütö G; Guth PH; Taché Y
Am J Physiol; 1998 Jan; 274(1):G170-7. PubMed ID: 9458786
[TBL] [Abstract][Full Text] [Related]
4. Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats.
Kawakubo K; Akiba Y; Adelson D; Guth PH; Engel E; Taché Y; Kaunitz JD
Peptides; 2005 Sep; 26(9):1580-9. PubMed ID: 16112396
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms mediating gastric hyperemic and acid responses to central TRH analog at a cytoprotective dose.
Király A; Sütó G; Guth PH; Taché Y
Am J Physiol; 1997 Jul; 273(1 Pt 1):G31-8. PubMed ID: 9252506
[TBL] [Abstract][Full Text] [Related]
6. Potent central nervous system action of p-Glu-His-(3,3'-dimethyl)-Pro NH2, a stabilized analog of TRH, to stimulate gastric secretion in rats.
Taché Y; Goto Y; Lauffenburger M; Lesiege D
Regul Pept; 1984 Jan; 8(1):71-8. PubMed ID: 6425995
[TBL] [Abstract][Full Text] [Related]
7. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats.
Yoneda M; Taché Y
Gastroenterology; 1992 May; 102(5):1568-74. PubMed ID: 1568566
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin-sensitive vagal afferents contribute to gastric acid and vascular responses to intracisternal TRH analog.
Raybould HE; Holzer P; Reddy SN; Yang H; Taché Y
Peptides; 1990; 11(4):789-95. PubMed ID: 2122423
[TBL] [Abstract][Full Text] [Related]
9. Influence of [4Cl-D-Phe6,Leu17]VIP on VIP- and central TRH-induced gastric hyperemia.
Király A; Sütó G; Guth P; Taché Y
Peptides; 1997; 18(9):1321-5. PubMed ID: 9392832
[TBL] [Abstract][Full Text] [Related]
10. Central vagal activation by TRH induces gastric hyperemia: role of CGRP in capsaicin-sensitive afferents in rats.
Kiràly A; Sütö G; Livingston EH; Guth PH; St Pierre S; Taché Y
Am J Physiol; 1994 Dec; 267(6 Pt 1):G1041-9. PubMed ID: 7810651
[TBL] [Abstract][Full Text] [Related]
11. Role of prostaglandins and calcitonin gene-related peptide in central vagal cholinergic-dependent protection against gastric injury in urethane-anesthetized rats.
Kato K; Yang H; Taché Y
Digestion; 1996; 57(5):322-7. PubMed ID: 8886575
[TBL] [Abstract][Full Text] [Related]
12. Central vagal activation increases mucus gel thickness and surface cell intracellular pH in rat stomach.
Tanaka S; Taché Y; Kaneko H; Guth PH; Kaunitz JD
Gastroenterology; 1997 Feb; 112(2):409-17. PubMed ID: 9024294
[TBL] [Abstract][Full Text] [Related]
13. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways.
Yang H; Kawakubo K; Taché Y
Am J Physiol; 1999 Sep; 277(3):G555-62. PubMed ID: 10484380
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
Joh T; Oshima T; Takahashi N; Kaneko H; Sasaki M; Kataoka H; Watanabe K; Sobue M; Suzuki H; Nomura T; Ohara H; Itoh M
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G230-4. PubMed ID: 15499083
[TBL] [Abstract][Full Text] [Related]
15. Involvement of vagal pathway in the anti-secretory effect of a novel xanthine derivative.
Tanaka T; Taché Y; Guth PH
Eur J Pharmacol; 1993 Oct; 243(3):221-5. PubMed ID: 8276073
[TBL] [Abstract][Full Text] [Related]
16. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
Yoneda M; Kurosawa M; Watanobe H; Terano A
J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
[TBL] [Abstract][Full Text] [Related]
17. Intracisternal PYY inhibits gastric lesions induced by ethanol in rats: role of PYY-preferring receptors?
Kawakubo K; Yang H; Taché Y
Brain Res; 2000 Jan; 854(1-2):30-4. PubMed ID: 10784103
[TBL] [Abstract][Full Text] [Related]
18. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms.
Taché Y; Yoneda M; Kato K; Király A; Sütö G; Kaneko H
J Gastroenterol Hepatol; 1994; 9 Suppl 1():S29-35. PubMed ID: 7881015
[TBL] [Abstract][Full Text] [Related]
19. Intracisternal TRH and RX 77368 potently activate gastric vagal efferent discharge in rats.
O-Lee TJ; Wei JY; Taché Y
Peptides; 1997; 18(2):213-9. PubMed ID: 9149293
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in gastric hyperemia induced by central vagal stimulation.
Tanaka T; Guth P; Taché Y
Am J Physiol; 1993 Feb; 264(2 Pt 1):G280-4. PubMed ID: 8447409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
